The DOI matches its Crossref record; 313 of the 313 references it cites were found in a registry or an index.
Stimuli-Responsive Therapeutic Metallodrugs
Abstract
The success of platinum-based anticancer agents has motivated the exploration of novel metal-based drugs for several decades, whereas problems such as drug-resistance and systemic toxicity hampered their clinical applications and efficacy. Stimuli-responsiveness of some metal complexes offers a good opportunity for designing site-specific prodrugs to maximize the therapeutic efficacy and minimize the side effect of metallodrugs. This review presents a comprehensive and up-to-date overview on the therapeutic stimuli-responsive metallodrugs that have appeared in the past two decades, where stimuli such as redox, pH, enzyme, light, temperature, and so forth were involved. The compounds are classified into three major categories based on the nature of stimuli, that is, endo-stimuli-responsive metallodrugs, exo-stimuli-responsive metallodrugs, and dual-stimuli-responsive metallodrugs. Representative examples of each type are discussed in terms of structure, response mechanism, and potential medical applications. In the end, future opportunities and challenges in this field are tentatively proposed. With diverse metal complexes being introduced, the foci of this review are pointed to platinum and ruthenium complexes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Aggregation-Induced Emission: Together We Shine, United We Soar!
Mei, J., Leung, N. L. C., Kwok, R. T. K., Lam, J. W. Y., & Tang, B. Z. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00263 · Cited by 8,270
Magnetic Nanoparticles: Synthesis, Protection, Functionalization, and Application
Lu, A., Salabas, E. L., & Schüth, F. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200602866 · Cited by 6,777
Photodynamic therapy for cancer
Dolmans, D. E. J. G. J., Fukumura, D., & Jain, R. K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1071 · Cited by 6,758
Hong, Y., Lam, J. W. Y., & Tang, B. Z. (2011) · Chemical Society Reviews · doi:10.1039/c1cs15113d · Cited by 6,363
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Applications of magnetic nanoparticles in biomedicine
Pankhurst, Q. A., Connolly, J., Jones, S. K., & Dobson, J. (2003) · Journal of Physics D: Applied Physics · doi:10.1088/0022-3727/36/13/201 · Cited by 5,881
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Schafer, F. Q., & Buettner, G. R. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00480-4 · Cited by 4,587
Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications
Caravan, P., Ellison, J. J., McMurry, T. J., & Lauffer, R. B. (1999) · Chemical Reviews · doi:10.1021/cr980440x · Cited by 4,483
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
ROS as signalling molecules: Mechanisms that generate specificity in ROS homeostasis
D'Autréaux, B., & Toledano, M. B. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2256 · Cited by 3,642
Nano-graphene oxide for cellular imaging and drug delivery
Sun, X., Liu, Z., Welsher, K., Robinson, J. T., Goodwin, A., Zaric, S., & Dai, H. (2008) · Nano Research · doi:10.1007/s12274-008-8021-8 · Cited by 3,291
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00597 · Cited by 2,485
Lysosomes: fusion and function
Luzio, J. P., Pryor, P. R., & Bright, N. A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2217 · Cited by 1,740
Mesoporous silica nanoparticles for drug delivery and biosensing applications
Slowing, I. I., Trewyn, B. G., Giri, S., & Lin, V. S. ‐. (2007) · Advanced Functional Materials · doi:10.1002/adfm.200601191 · Cited by 1,699
Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function
Saftig, P., & Klumperman, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2745 · Cited by 1,648
Prodrugs: design and clinical applications
Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D., Järvinen, T., & Savolainen, J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2468 · Cited by 1,630
Interfering with pH regulation in tumours as a therapeutic strategy
Neri, D., & Supuran, C. T. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3554 · Cited by 1,547
Bonnet, S., Archer, S. L., Allalunis-Turner, J., Haromy, A., Beaulieu, C., Thompson, R., Lee, C. T., Lopaschuk, G. D., Puttagunta, L., Bonnet, S., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.020 · Cited by 1,530
Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems
Karimi, M., Ghasemi, A., Sahandi Zangabad, P., Rahighi, R., Moosavi Basri, S. M., Mirshekari, H., Amiri, M., Shafaei Pishabad, Z., Aslani, A., Bozorgomid, M., et al. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00798d · Cited by 1,519
Saito, G., Swanson, J. A., & Lee, K.-D. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00179-5 · Cited by 1,407
Cheng, R., Feng, F., Meng, F., Deng, C., Feijen, J., & Zhong, Z. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.030 · Cited by 1,360
Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug
(1999) · Wiley eBooks · doi:10.1002/9783906390420 · Cited by 1,296
Metallodrugs in Medicinal Inorganic Chemistry
Mjos, K. D., & Orvig, C. (2014) · Chemical Reviews · doi:10.1021/cr400460s · Cited by 1,289
Lanthanide Probes for Bioresponsive Imaging
Heffern, M. C., Matosziuk, L. M., & Meade, T. J. (2014) · Chemical Reviews · doi:10.1021/cr400477t · Cited by 1,202
Desai, N., Trieu, V., Yao, Z., Louie, L., Ci, S., Yang, A., Tao, C., De, T., Beals, B., Dykes, D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1634 · Cited by 1,175
Reduction-sensitive polymers and bioconjugates for biomedical applications
Meng, F., Hennink, W. E., & Zhong, Z. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.026 · Cited by 1,131
The Smart Drug Delivery System and Its Clinical Potential
Liu, D., Yang, F., Xiong, F., & Gu, N. (2016) · Theranostics · doi:10.7150/thno.14858 · Cited by 1,066
Zeng, L., Gupta, P., Chen, Y., Wang, E., Ji, L., Chao, H., & Chen, Z.-S. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00195a · Cited by 1,017
Dhar, S., Gu, F. X., Langer, R., Farokhzad, O. C., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809154105 · Cited by 994
Bioorganometallic chemistry—from teaching paradigms to medicinal applications
Hartinger, C. G., & Dyson, P. J. (2009) · Chem. Soc. Rev. · doi:10.1039/b707077m · Cited by 985
Nebert, D. W., & Dalton, T. P. (2006) · Nature Reviews Cancer · doi:10.1038/nrc2015 · Cited by 958
Hartinger, C. G., Zorbas-Seifried, S., Jakupec, M. A., Kynast, B., Zorbas, H., & Keppler, B. K. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.02.013 · Cited by 956
Photodynamic therapeutics: basic principles and clinical applications
Sharman, W. M., Allen, C. M., & van Lier, J. E. (1999) · Drug Discovery Today · doi:10.1016/s1359-6446(99)01412-9 · Cited by 925
Guo, Z., & Sadler, P. J. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990601)38:11<1512::aid-anie1512>3.0.co;2-y · Cited by 834
Self-citationHartinger, C. G., Jakupec, M. A., Zorbas‐Seifried, S., Groessl, M., Egger, A., Berger, W., Zorbas, H., Dyson, P. J., & Keppler, B. K. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890195 · Cited by 830
Inhibition of Cancer Cell Growth by Ruthenium(II) Arene Complexes
Morris, R. E., Aird, R. E., del Socorro Murdoch, P., Chen, H., Cummings, J., Hughes, N. D., Parsons, S., Parkin, A., Boyd, G., Jodrell, D. I., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010051m · Cited by 787
Noble metals in medicine: Latest advances
Medici, S., Peana, M., Nurchi, V. M., Lachowicz, J. I., Crisponi, G., & Zoroddu, M. A. (2014) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2014.08.002 · Cited by 755
Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy
Li, H.-J., Du, J.-Z., Du, X.-J., Xu, C.-F., Sun, C.-Y., Wang, H.-X., Cao, Z.-T., Yang, X.-Z., Zhu, Y.-H., Nie, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522080113 · Cited by 724
Dhar, S., Liu, Z., Thomale, J., Dai, H., & Lippard, S. J. (2008) · Journal of the American Chemical Society · doi:10.1021/ja803036e · Cited by 700
Targeting and delivery of platinum-based anticancer drugs
Wang, X., & Guo, Z. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35259a · Cited by 684
Self-citationPlatinum(IV) antitumour compounds: their bioinorganic chemistry
Hall, M. D., & Hambley, T. W. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00026-7 · Cited by 622
Feazell, R. P., Nakayama-Ratchford, N., Dai, H., & Lippard, S. J. (2007) · Journal of the American Chemical Society · doi:10.1021/ja073231f · Cited by 616
Recent developments in ruthenium anticancer drugs
Levina, A., Mitra, A., & Lay, P. A. (2009) · Metallomics · doi:10.1039/b904071d · Cited by 592
van Rijt, S. H., & Sadler, P. J. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.09.003 · Cited by 592
DNA Cross-Linking Agents as Antitumor Drugs
Rajski, S. R., & Williams, R. M. (1998) · Chemical Reviews · doi:10.1021/cr9800199 · Cited by 592
Combination of Ru(ii) complexes and light: new frontiers in cancer therapy
Mari, C., Pierroz, V., Ferrari, S., & Gasser, G. (2015) · Chemical Science · doi:10.1039/c4sc03759f · Cited by 570
“SMART” Drug Delivery Systems: Double-Targeted pH-Responsive Pharmaceutical Nanocarriers
Sawant, R. M., Hurley, J. P., Salmaso, S., Kale, A., Tolcheva, E., Levchenko, T. S., & Torchilin, V. P. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060080h · Cited by 540
Therapeutic and diagnostic applications of dendrimers for cancer treatment☆
WOLINSKY, J., & GRINSTAFF, M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.02.012 · Cited by 540
Dai, Y., Xiao, H., Liu, J., Yuan, Q., Ma, P., Yang, D., Li, C., Cheng, Z., Hou, Z., Yang, P., et al. (2013) · Journal of the American Chemical Society · doi:10.1021/ja410028q · Cited by 529
Redox activation of metal-based prodrugs as a strategy for drug delivery
Graf, N., & Lippard, S. J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.01.007 · Cited by 523
Cheng, Y., Zhao, L., Li, Y., & Xu, T. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00097c · Cited by 515
Metal-based anticancer chemotherapeutic agents
Muhammad, N., & Guo, Z. (2014) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2014.02.003 · Cited by 515
Self-citationDhar, S., Daniel, W. L., Giljohann, D. A., Mirkin, C. A., & Lippard, S. J. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9071282 · Cited by 510
Prodrugs—from Serendipity to Rational Design
Huttunen, K. M., Raunio, H., & Rautio, J. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003459 · Cited by 505
Development and applications of photo-triggered theranostic agents
Rai, P., Mallidi, S., Zheng, X., Rahmanzadeh, R., Mir, Y., Elrington, S., Khurshid, A., & Hasan, T. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.09.002 · Cited by 504
Strained Ruthenium Complexes Are Potent Light-Activated Anticancer Agents
Howerton, B. S., Heidary, D. K., & Glazer, E. C. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3009677 · Cited by 498
Prodrug Strategies in Anticancer Chemotherapy
Kratz, F., Müller, I. A., Ryppa, C., & Warnecke, A. (2008) · ChemMedChem · doi:10.1002/cmdc.200700159 · Cited by 486
Ruthenium Antimetastatic Agents
Alessio, E., Mestroni, G., Bergamo, A., & Sava, G. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043387421 · Cited by 479
pH-sensitive vesicles, polymeric micelles, and nanospheres prepared with polycarboxylates
Felber, A. E., Dufresne, M.-H., & Leroux, J.-C. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.09.006 · Cited by 478
Karran, P., & Attard, N. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2292 · Cited by 477
Yuan, Y., Kwok, R. T. K., Tang, B. Z., & Liu, B. (2014) · Journal of the American Chemical Society · doi:10.1021/ja411811w · Cited by 474
Basis for Design and Development of Platinum(IV) Anticancer Complexes
Hall, M. D., Mellor, H. R., Callaghan, R., & Hambley, T. W. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070280u · Cited by 458
Huang, H., Yu, B., Zhang, P., Huang, J., Chen, Y., Gasser, G., Ji, L., & Chao, H. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201507800 · Cited by 449
Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs
Bergamo, A., & Sava, G. (2011) · Dalton Transactions · doi:10.1039/c0dt01816c · Cited by 440
Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery
Zheng, Y.-R., Suntharalingam, K., Johnstone, T. C., Yoo, H., Lin, W., Brooks, J. G., & Lippard, S. J. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5038269 · Cited by 440
Meier-Menches, S. M., Gerner, C., Berger, W., Hartinger, C. G., & Keppler, B. K. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00332c · Cited by 425
Stimuli responsive drug delivery systems based on nano-graphene for cancer therapy
Yang, K., Feng, L., & Liu, Z. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.05.015 · Cited by 415
Shi, H., Liu, J., Geng, J., Tang, B. Z., & Liu, B. (2012) · Journal of the American Chemical Society · doi:10.1021/ja302369e · Cited by 402
Polymer−Cisplatin Conjugate Nanoparticles for Acid-Responsive Drug Delivery
Aryal, S., Hu, C.-M. J., & Zhang, L. (2010) · ACS Nano · doi:10.1021/nn9014032 · Cited by 400
Nanocarriers for delivery of platinum anticancer drugs
Oberoi, H. S., Nukolova, N. V., Kabanov, A. V., & Bronich, T. K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.014 · Cited by 396
Next-Generation Metal Anticancer Complexes: Multitargeting via Redox Modulation
Romero-Canelón, I., & Sadler, P. J. (2013) · Inorganic Chemistry · doi:10.1021/ic400835n · Cited by 396
Stimuli-Responsive Polymersomes for Biomedical Applications
Hu, X., Zhang, Y., Xie, Z., Jing, X., Bellotti, A., & Gu, Z. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.6b01704 · Cited by 394
Cyclodextrin-based gene delivery systems
Mellet, C. O., Fernández, J. M. G., & Benito, J. M. (2011) · Chem. Soc. Rev. · doi:10.1039/c0cs00019a · Cited by 393
Molecular tracers for the PET and SPECT imaging of disease
Pimlott, S. L., & Sutherland, A. (2011) · Chem. Soc. Rev. · doi:10.1039/b922628c · Cited by 379
Leijen, S., Burgers, S. A., Baas, P., Pluim, D., Tibben, M., van Werkhoven, E., Alessio, E., Sava, G., Beijnen, J. H., & Schellens, J. H. M. (2015) · Investigational New Drugs · doi:10.1007/s10637-014-0179-1 · Cited by 374
What do we know about the reduction of Pt(IV) pro-drugs?
Wexselblatt, E., & Gibson, D. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.06.013 · Cited by 370
Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate
Dhar, S., & Lippard, S. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912276106 · Cited by 369
Duenas-Gonzalez, A., Candelaria, M., Perez-Plascencia, C., Perez-Cardenas, E., de la Cruz-Hernandez, E., & Herrera, L. A. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.11.003 · Cited by 354
Platinum Drug Distribution in Cancer Cells and Tumors
Klein, A. V., & Hambley, T. W. (2009) · Chemical Reviews · doi:10.1021/cr9001066 · Cited by 351
Photoactivated Biological Activity of Transition‐Metal Complexes
Schatzschneider, U. (2010) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.201000003 · Cited by 349
Xu, X., Xie, K., Zhang, X.-Q., Pridgen, E. M., Park, G. Y., Cui, D. S., Shi, J., Wu, J., Kantoff, P. W., Lippard, S. J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303958110 · Cited by 340
Developing new metal-based therapeutics: challenges and opportunities
Hambley, T. W. (2007) · Dalton Transactions · doi:10.1039/b706075k · Cited by 337
αVβ3 Integrin-Targeted PLGA-PEG Nanoparticles for Enhanced Anti-tumor Efficacy of a Pt(IV) Prodrug
Graf, N., Bielenberg, D. R., Kolishetti, N., Muus, C., Banyard, J., Farokhzad, O. C., & Lippard, S. J. (2012) · ACS Nano · doi:10.1021/nn301148e · Cited by 327
Recent developments in lanthanide-based luminescent probes
Wang, X., Chang, H., Xie, J., Zhao, B., Liu, B., Xu, S., Pei, W., Ren, N., Huang, L., & Huang, W. (2014) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2014.02.001 · Cited by 323
Self-citationWachter, E., Heidary, D. K., Howerton, B. S., Parkin, S., & Glazer, E. C. (2012) · Chemical Communications · doi:10.1039/c2cc33359g · Cited by 317
Chen, Q., Wang, C., Cheng, L., He, W., Cheng, Z., & Liu, Z. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.046 · Cited by 315
Ang, W. H., Khalaila, I., Allardyce, C. S., Juillerat-Jeanneret, L., & Dyson, P. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0432618 · Cited by 314
Prodrug-based intracellular delivery of anticancer agents
Bildstein, L., Dubernet, C., & Couvreur, P. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.12.005 · Cited by 310
Min, Y., Li, J., Liu, F., Yeow, E. K. L., & Xing, B. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201308834 · Cited by 309
Enzyme responsive materials: design strategies and future developments
Zelzer, M., Todd, S. J., Hirst, A. R., McDonald, T. O., & Ulijn, R. V. (2013) · Biomater. Sci. · doi:10.1039/c2bm00041e · Cited by 306
From structure to function via complex supramolecular dendrimer systems
Sun, H.-J., Zhang, S., & Percec, V. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00249k · Cited by 304
Catalytic organometallic anticancer complexes
Dougan, S. J., Habtemariam, A., McHale, S. E., Parsons, S., & Sadler, P. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800076105 · Cited by 303
A potent cytotoxic photoactivated platinum complex
Mackay, F. S., Woods, J. A., Heringová, P., Kašpárková, J., Pizarro, A. M., Moggach, S. A., Parsons, S., Brabec, V., & Sadler, P. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707742105 · Cited by 303
Bartholomä, M. D., Louie, A. S., Valliant, J. F., & Zubieta, J. (2010) · Chemical Reviews · doi:10.1021/cr1000755 · Cited by 298
Prodrug strategies in cancer therapy
Denny, W. A. (2001) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01253-3 · Cited by 290
Biological Activity of Complex Ions
DWYER, F. P., GYARFAS, E. C., ROGERS, W. P., & KOCH, J. H. (1952) · Nature · doi:10.1038/170190a0 · Cited by 289
Prodrugs in medicinal chemistry and enzyme prodrug therapies
Walther, R., Rautio, J., & Zelikin, A. N. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.06.013 · Cited by 288
Platinum(iv) anticancer prodrugs – hypotheses and facts
Gibson, D. (2016) · Dalton Transactions · doi:10.1039/c6dt01414c · Cited by 286
Liu, J., Chen, Y., Li, G., Zhang, P., Jin, C., Zeng, L., Ji, L., & Chao, H. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.04.002 · Cited by 280
Redox‐Active Metal Complexes for Anticancer Therapy
Zhang, P., & Sadler, P. J. (2017) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.201600908 · Cited by 274
Thermo and pH Dual‐Responsive Nanoparticles for Anti‐Cancer Drug Delivery
Zhang, L., Guo, R., Yang, M., Jiang, X., & Liu, B. (2007) · Advanced Materials · doi:10.1002/adma.200601817 · Cited by 269
Functionalization of Platinum Complexes for Biomedical Applications
Wang, X., Wang, X., & Guo, Z. (2015) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00203 · Cited by 268
Self-citationLv, Z., Wei, H., Li, Q., Su, X., Liu, S., Zhang, K. Y., Lv, W., Zhao, Q., Li, X., & Huang, W. (2018) · Chemical Science · doi:10.1039/c7sc03765a · Cited by 268
Niesel, J., Pinto, A., Peindy N'Dongo, H. W., Merz, K., Ott, I., Gust, R., & Schatzschneider, U. (2008) · Chemical Communications · doi:10.1039/b719075a · Cited by 267
Advances in Platinum Chemotherapeutics
Harper, B. W., Krause‐Heuer, A. M., Grant, M. P., Manohar, M., Garbutcheon‐Singh, K. B., & Aldrich‐Wright, J. R. (2010) · Chemistry – A European Journal · doi:10.1002/chem.201000148 · Cited by 267
Barnes, K. R., Kutikov, A., & Lippard, S. J. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.03.024 · Cited by 263
Aminoferrocene-Based Prodrugs Activated by Reactive Oxygen Species
Hagen, H., Marzenell, P., Jentzsch, E., Wenz, F., Veldwijk, M. R., & Mokhir, A. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm2014937 · Cited by 260
The Prodrug Platin‐A: Simultaneous Release of Cisplatin and Aspirin
Pathak, R. K., Marrache, S., Choi, J. H., Berding, T. B., & Dhar, S. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201308899 · Cited by 255
Rim, H. P., Min, K. H., Lee, H. J., Jeong, S. Y., & Lee, S. C. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201101536 · Cited by 247
Group 9 Organometallic Compounds for Therapeutic and Bioanalytical Applications
Ma, D.-L., Chan, D. S.-H., & Leung, C.-H. (2014) · Accounts of Chemical Research · doi:10.1021/ar500310z · Cited by 246
Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery
Zhang, Z., Huey Lee, S., & Feng, S.-S. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.12.018 · Cited by 238
Targeted delivery of platinum-based anticancer complexes
Butler, J. S., & Sadler, P. J. (2013) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2013.01.004 · Cited by 237
Synthesis and applications of stimuli-responsive hyperbranched polymers
Wang, D., Jin, Y., Zhu, X., & Yan, D. (2017) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2016.09.005 · Cited by 230
Farrell, N. P. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00201j · Cited by 229
Elucidation of the mechanism enabling tumor selective prodrug monotherapy.
Bosslet, K., Straub, R. H., Blumrich, M., Czech, J., Gerken, M., Sperker, B., Kroemer, H. K., Gesson, J., Koch, M. C., & Monneret, C. (1998) · PubMed · Cited by 225
Combating the Drug Resistance of Cisplatin Using a Platinum Prodrug Based Delivery System
Min, Y., Mao, C., Chen, S., Ma, G., Wang, J., & Liu, Y. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201201562 · Cited by 222
Sgambellone, M. A., David, A., Garner, R. N., Dunbar, K. R., & Turro, C. (2013) · Journal of the American Chemical Society · doi:10.1021/ja4045604 · Cited by 217
Stimuli-responsive polymersomes and nanoreactors
Che, H., & van Hest, J. C. M. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb01163b · Cited by 215
A New Strategy for Neurochemical Photodelivery: Metal−Ligand Heterolytic Cleavage
Zayat, L., Calero, C., Alborés, P., Baraldo, L., & Etchenique, R. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0278943 · Cited by 213
Visible‐Light‐Induced Annihilation of Tumor Cells with Platinum–Porphyrin Conjugates
Naik, A., Rubbiani, R., Gasser, G., & Spingler, B. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201400533 · Cited by 212
A Red‐Light‐Activated Ruthenium‐Caged NAMPT Inhibitor Remains Phototoxic in Hypoxic Cancer Cells
Lameijer, L. N., Ernst, D., Hopkins, S. L., Meijer, M. S., Askes, S. H. C., Le Dévédec, S. E., & Bonnet, S. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201703890 · Cited by 212
Recent synthesis of aminophosphonic acids as potential biological importance
Naydenova, E. D., Todorov, P. T., & Troev, K. D. (2010) · Amino Acids · doi:10.1007/s00726-009-0254-7 · Cited by 210
Albani, B. A., Peña, B., Leed, N. A., de Paula, N. A. B. G., Pavani, C., Baptista, M. S., Dunbar, K. R., & Turro, C. (2014) · Journal of the American Chemical Society · doi:10.1021/ja508272h · Cited by 210
Platinum-based inhibitors of amyloid-β as therapeutic agents for Alzheimer's disease
Barnham, K. J., Kenche, V. B., Ciccotosto, G. D., Smith, D. P., Tew, D. J., Liu, X., Perez, K., Cranston, G. A., Johanssen, T. J., Volitakis, I., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800712105 · Cited by 209
He, Q., Liang, C. H., & Lippard, S. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100108697 · Cited by 209
von Heideman, A., Berglund, Å., Larsson, R., & Nygren, P. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1125-3 · Cited by 201
Evolving anticancer drug valproic acid: Insights into the mechanism and clinical studies
Blaheta, R. A., Michaelis, M., Driever, P. H., & Cinatl, J. (2005) · Medicinal Research Reviews · doi:10.1002/med.20027 · Cited by 198
Ware, D. C., Palmer, B. D., Wilson, W. R., & Denny, W. A. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00065a006 · Cited by 193
Recent advances in the diagnosis and treatment of bladder cancer
Cheung, G., Sahai, A., Billia, M., Dasgupta, P., & Khan, M. S. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-13 · Cited by 190
Rose, M. J., Fry, N. L., Marlow, R., Hinck, L., & Mascharak, P. K. (2008) · Journal of the American Chemical Society · doi:10.1021/ja801823f · Cited by 188
Staderini, M., Martín, M. A., Bolognesi, M. L., & Menéndez, J. C. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00337c · Cited by 187
DNA Intercalating RuII Polypyridyl Complexes as Effective Photosensitizers in Photodynamic Therapy
Mari, C., Pierroz, V., Rubbiani, R., Patra, M., Hess, J., Spingler, B., Oehninger, L., Schur, J., Ott, I., Salassa, L., et al. (2014) · Chemistry – A European Journal · doi:10.1002/chem.201402796 · Cited by 185
Raveendran, R., Braude, J. P., Wexselblatt, E., Novohradsky, V., Stuchlikova, O., Brabec, V., Gandin, V., & Gibson, D. (2016) · Chemical Science · doi:10.1039/c5sc04205d · Cited by 183
Combating the Drug Resistance of Cisplatin Using a Platinum Prodrug Based Delivery System
Min, Y., Mao, C., Chen, S., Ma, G., Wang, J., & Liu, Y. (2012) · Angewandte Chemie · doi:10.1002/ange.201201562 · Cited by 181
A review of optical imaging and therapy using nanosized graphene and graphene oxide
Li, J.-L., Tang, B., Yuan, B., Sun, L., & Wang, X.-G. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.066 · Cited by 179
Self-citationStimuli‐Responsive Polymeric Nanoparticles for Nanomedicine
Crucho, C. I. C. (2015) · ChemMedChem · doi:10.1002/cmdc.201402290 · Cited by 173
Anticancer Efficacies of Cisplatin-Releasing pH-Responsive Nanoparticles
Xu, P., Van Kirk, E. A., Murdoch, W. J., Zhan, Y., Isaak, D. D., Radosz, M., & Shen, Y. (2006) · Biomacromolecules · doi:10.1021/bm050902y · Cited by 171
Efficacy of Dichloroacetate as a Lactate-Lowering Drug
Stacpoole, P. W., Nagaraja, N. V., & Hutson, A. D. (2003) · Journal of Clinical Pharmacology · doi:10.1177/0091270003043007001 · Cited by 171
Folkes, L. K., & Wardman, P. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00498-6 · Cited by 166
Patra, M., Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201510551 · Cited by 160
Cisplatin delivery from poly(acrylic acid-co-methyl methacrylate) microparticles
Yan, X., & Gemeinhart, R. A. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.05.005 · Cited by 158
Classification of stimuli–responsive polymers as anticancer drug delivery systems
Taghizadeh, B., Taranejoo, S., Monemian, S., Moghaddam, Z. S., Daliri, K., Derakhshankhah, H., & Derakhshani, Z. (2014) · Drug Delivery · doi:10.3109/10717544.2014.887157 · Cited by 157
Metal complexes as potential modulators of inflammatory and autoimmune responses
Leung, C., Lin, S., Zhong, H., & Ma, D. (2014) · Chemical Science · doi:10.1039/c4sc03094j · Cited by 157
Inhibitors of glutathione S-transferases as therapeutic agents
Schultz, M., Dutta, S., & Tew, K. D. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00029-x · Cited by 155
Stimuli-responsive polymersomes for cancer therapy
Thambi, T., Park, J. H., & Lee, D. S. (2015) · Biomaterials Science · doi:10.1039/c5bm00268k · Cited by 152
Marker, S. C., MacMillan, S. N., Zipfel, W. R., Li, Z., Ford, P. C., & Wilson, J. J. (2018) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.7b02747 · Cited by 150
Satraplatin: leading the new generation of oral platinum agents
Bhargava, A., & Vaishampayan, U. N. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903362437 · Cited by 149
Challenges for Metals in Medicine: How Nanotechnology May Help To Shape the Future
Barry, N. P. E., & Sadler, P. J. (2013) · ACS Nano · doi:10.1021/nn403220e · Cited by 148
Native albumin for targeted drug delivery
Neumann, E., Frei, E., Funk, D., Becker, M. D., Schrenk, H., Müller‐Ladner, U., & Fiehn, C. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2010.498474 · Cited by 147
Nyström, A. M., & Wooley, K. L. (2011) · Accounts of Chemical Research · doi:10.1021/ar200097k · Cited by 146
Respondek, T., Garner, R. N., Herroon, M. K., Podgorski, I., Turró, C., & Kodanko, J. J. (2011) · Journal of the American Chemical Society · doi:10.1021/ja208084s · Cited by 145
Patra, M., Awuah, S. G., & Lippard, S. J. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b06937 · Cited by 145
Failes, T. W., Cullinane, C. M., Diakos, C. I., Yamamoto, N., Lyons, J. G., & Hambley, T. W. (2006) · Chemistry - A European Journal · doi:10.1002/chem.200601137 · Cited by 143
Vitamin E succinate and cancer treatment: a vitamin E prototype for selective antitumour activity
Neužil, J. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601360 · Cited by 137
Prodrug strategy for cancer cell-specific targeting: A recent overview
Zhang, X., Li, X., You, Q., & Zhang, X. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.08.010 · Cited by 134
Venkataramani, V., Rossner, C., Iffland, L., Schweyer, S., Tamboli, I. Y., Walter, J., Wirths, O., & Bayer, T. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.057836 · Cited by 133
Mitra, K., Gautam, S., Kondaiah, P., & Chakravarty, A. R. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201507281 · Cited by 132
Ruthenium−Porphyrin Conjugates with Cytotoxic and Phototoxic Antitumor Activity
Gianferrara, T., Bergamo, A., Bratsos, I., Milani, B., Spagnul, C., Sava, G., & Alessio, E. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1002588 · Cited by 130
Nicotinamide Phosphoribosyltransferase in Human Diseases
Zhang, L. Q., Heruth, D. P., & Ye, S. Q. (2011) · Journal of Bioanalysis & Biomedicine · doi:10.4172/1948-593x.1000038 · Cited by 129
An Iron Complex of Dipyridophenazine as a Potent Photocytotoxic Agent in Visible Light
Saha, S., Majumdar, R., Roy, M., Dighe, R. R., & Chakravarty, A. R. (2009) · Inorganic Chemistry · doi:10.1021/ic8022612 · Cited by 129
Cheng, Z., Dai, Y., Kang, X., Li, C., Huang, S., Lian, H., Hou, Z., Ma, P., & Lin, J. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.029 · Cited by 128
Conjugate of Pt(IV)–Histone Deacetylase Inhibitor as a Prodrug for Cancer Chemotherapy
Yang, J. J., Sun, X., Mao, W., Sui, M., Tang, J., & Shen, Y. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200597r · Cited by 127
Mechanism-based inactivation of dihydropyrimidine dehydrogenase by 5-ethynyluracil.
Porter, D. J., Chestnut, W. G., Merrill, B. M., & Spector, T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42757-3 · Cited by 123
Li, J., Lyv, Z., Li, Y., Liu, H., Wang, J., Zhan, W., Chen, H., Chen, H., & Li, X. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.01.074 · Cited by 123
Yoong, S. L., Wong, B. S., Zhou, Q., Chin, C. F., Li, J., Venkatesan, T., Ho, H. K., Yu, V. C. K., Ang, W. H., & Pastorin, G. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.036 · Cited by 123
Cogswell, S., Berger, S. A., Waterhouse, D., Bally, M. B., & Wasan, E. K. (2006) · Pharmaceutical Research · doi:10.1007/pl00022054 · Cited by 122
Xia, H., Li, F., Hu, X., Park, W., Wang, S., Jang, Y. J., Du, Y., Baik, S., Cho, S., Kang, T., et al. (2016) · ACS Central Science · doi:10.1021/acscentsci.6b00197 · Cited by 122
Immuno‐Chemotherapeutic Platinum(IV) Prodrugs of Cisplatin as Multimodal Anticancer Agents
Wong, D. Y. Q., Yeo, C. H. F., & Ang, W. H. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201402879 · Cited by 121
A Telomerase‐Specific Doxorubicin‐Releasing Molecular Beacon for Cancer Theranostics
Ma, Y., Wang, Z., Zhang, M., Han, Z., Chen, D., Zhu, Q., Gao, W., Qian, Z., & Gu, Y. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201509182 · Cited by 121
A Phase I study of CHS 828 in patients with solid tumor malignancy.
Hovstadius, P., Larsson, R. L., Jonsson, E., Skov, T., Kissmeyer, A., Krasilnikoff, K., Bergh, J. C. S., Karlsson, M. O., Lönnebo, A., & Ahlgren, J. (2002) · PubMed · Cited by 119
Photorelease of GABA with visible light using an inorganic caging group
Verde, E. R., Zayat, L., Etchenique, R., & Yuste, R. (2008) · Frontiers in Neural Circuits · doi:10.3389/neuro.04.002.2008 · Cited by 118
Gandioso, A., Shaili, E., Massaguer, A., Artigas, G., González-Cantó, A., Woods, J. A., Sadler, P. J., & Marchán, V. (2015) · Chemical Communications · doi:10.1039/c5cc03180j · Cited by 116
Applications of stimuli-responsive nanoscale drug delivery systems in translational research
Gu, M., Wang, X., Toh, T. B., & Chow, E. K. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.11.009 · Cited by 116
Self-citationIndole-3-propionate: a potent hydroxyl radical scavenger in rat brain
Pöeggeler, B., Pappolla, M. A., Hardeland, R., Rassoulpour, A., Hodgkins, P., Guidetti, P., & Schwarcz, R. M. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01027-0 · Cited by 114
Cyclodextrin-based siRNA delivery nanocarriers: a state-of-the-art review
Chaturvedi, K., Ganguly, K., Kulkarni, A. R., Kulkarni, V. H., Nadagouda, M. N., Rudzinski, W. E., & Aminabhavi, T. M. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.610790 · Cited by 114
Shiau, C.-W., Huang, J.-W., Wang, D.-S., Weng, J.-R., Yang, C.-C., Lin, C.-H., Li, C., & Chen, C.-S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511015200 · Cited by 113
A GSH-activatable ruthenium( ii )-azo photosensitizer for two-photon photodynamic therapy
Zeng, L., Kuang, S., Li, G., Jin, C., Ji, L., & Chao, H. (2017) · Chemical Communications · doi:10.1039/c6cc10330h · Cited by 113
Conjugation of vitamin E analog α-TOS to Pt(iv) complexes for dual-targeting anticancer therapy
Suntharalingam, K., Song, Y., & Lippard, S. J. (2013) · Chemical Communications · doi:10.1039/c3cc48740g · Cited by 112
Chen, H., He, W., & Guo, Z. (2014) · Chemical Communications · doi:10.1039/c4cc03385j · Cited by 111
Self-citationPros and cons of bifunctional platinum(iv) antitumor prodrugs: two are (not always) better than one
Gabano, E., Ravera, M., & Osella, D. (2014) · Dalton Transactions · doi:10.1039/c4dt00911h · Cited by 111
Conjugation of Cisplatin Analogues and Cyclooxygenase Inhibitors to Overcome Cisplatin Resistance
Neumann, W., Crews, B. C., Sárosi, M. B., Daniel, C. M., Ghebreselasie, K., Scholz, M., Marnett, L. J., & Hey‐Hawkins, E. (2014) · ChemMedChem · doi:10.1002/cmdc.201402353 · Cited by 111
Dickerson, M. T., Sun, Y., Howerton, B. S., & Glazer, E. C. (2014) · Inorganic Chemistry · doi:10.1021/ic5013796 · Cited by 109
Soluble Tetraarylporphyrin−Platinum Conjugates as Cytotoxic and Phototoxic Antitumor Agents
Lottner, C., Bart, K.-C., Bernhardt, G., & Brunner, H. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0110690 · Cited by 108
Stimuli responsive drug delivery application of polymer and silica in biomedicine
Gulzar, A., Gai, S., Yang, P., Li, C., Ansari, M. B., & Lin, J. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb00757g · Cited by 107
A New Inorganic Photolabile Protecting Group for Highly Efficient Visible Light GABA Uncaging
Zayat, L., Noval, M. G., Campi, J., Calero, C. I., Calvo, D. J., & Etchenique, R. (2007) · ChemBioChem · doi:10.1002/cbic.200700354 · Cited by 106
Sainuddin, T., McCain, J., Pinto, M., Yin, H., Gibson, J., Hetu, M., & McFarland, S. A. (2015) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.5b01838 · Cited by 106
Scarano, W., Duong, H. T. T., Lu, H., de Souza, P. L., & Stenzel, M. H. (2013) · Biomacromolecules · doi:10.1021/bm400121q · Cited by 105
Xiao, H., Noble, G. T., Stefanick, J. F., Qi, R., Kiziltepe, T., Jing, X., & Bilgiçer, B. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.10.020 · Cited by 104
Kim, J. A., Kim, Y., Kwon, B., & Han, D. C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.488346 · Cited by 104
Endogenous Stimuli-responsive Nanocarriers for Drug Delivery
Chen, H., Liu, D., & Guo, Z. (2016) · Chemistry Letters · doi:10.1246/cl.151176 · Cited by 104
Self-citationThermogelling Polymer–Platinum(IV) Conjugates for Long-Term Delivery of Cisplatin
Shen, W., Luan, J., Cao, L., Sun, J., Yu, L., & Ding, J. (2014) · Biomacromolecules · doi:10.1021/bm501220a · Cited by 103
Lee, S. S.-Y., Li, J., tai, J. N., Ratliff, T. L., Park, K., & Cheng, J. (2015) · ACS Nano · doi:10.1021/nn504025a · Cited by 103
The Platin-X series: activation, targeting, and delivery
Basu, U., Banik, B., Wen, R. M., Pathak, R., & Dhar, S. (2016) · Dalton Transactions · doi:10.1039/c6dt01738j · Cited by 103
Zhao, Y., Woods, J. A., Farrer, N. J., Robinson, K. S., Prachařová, J., Kašpárková, J., Nováková, O., Li, H., Salassa, L., Pizarro, A. M., et al. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201300374 · Cited by 101
Fu, Y., Romero, M. J., Habtemariam, A., Snowden, M. E., Song, L., Clarkson, G. J., Qamar, B., Pizarro, A. M., Unwin, P. R., & Sadler, P. J. (2012) · Chemical Science · doi:10.1039/c2sc20220d · Cited by 101
Cited by
Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
Pham, T. C., Nguyen, V.-N., Choi, Y., Lee, S., & Yoon, J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00381 · Cited by 1,813
Tian, H., Zhang, T., Qin, S., Huang, Z., Zhou, L., Shi, J., Nice, E. C., Xie, N., Huang, C., & Shen, Z. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01320-5 · Cited by 426
Supramolecular cancer nanotheranostics
Zhou, J., Rao, L., Yu, G., Cook, T. R., Chen, X., & Huang, F. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00011f · Cited by 411
Stimuli-Responsive Polymer-Based Nanosystems for Cancer Theranostics
Wei, D., Sun, Y., Zhu, H., & Fu, Q. (2023) · ACS Nano · doi:10.1021/acsnano.3c06019 · Cited by 303
Stimuli‐Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy
Zhang, J., Lin, Y., Lin, Z., Wei, Q., Qian, J., Ruan, R., Jiang, X., Hou, L., Song, J., Ding, J., et al. (2022) · Advanced Science · doi:10.1002/advs.202103444 · Cited by 292
Metadata
- Authors
- Wang, X., Wang, X., Jin, S., Muhammad, N., & Guo, Z.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-10-09
- Volume
- 119
- Issue
- 2
- Pages
- 1138-1192
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2896130004
- Cited by
- 649
- References
- 313
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.